from the Court of Appeal of California, First Appellate District
See other cases from California.
Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.
Waiver of right of respondent Allergan, Inc. to respond filed.
Waiver of right of respondent Amgen, Inc. to respond filed.
Waiver of right of respondent AstraZeneca, LP to respond filed.
Waiver of right of respondent Boehringer Ingelheim Pharmaceuticals, Inc. to respond filed.
Waiver of right of respondent Bristol-Myers Squibb Company to respond filed.
Waiver of right of respondent Eli Lilly and Company to respond filed.
Waiver of right of respondent Abbott Laboratories to respond filed.
Waiver of right of respondent Novartis Pharmaceuticals Corporation to respond filed.
Waiver of right of respondents Pfizer, Inc., et al. to respond filed.
Waiver of right of respondent Pharmaceutical Research and Manufacturers of America (PhRMA) to respond filed.
Waiver of right of respondent GlaxoSmithKline plc to respond filed.
Waiver of right of respondent Hoffmann-La Roche, Inc. to respond filed.
Waiver of right of respondents Janssen Pharmaceutica, Inc, et al. to respond filed.
Waiver of right of respondent Merck Sharp & Dohme Corp. to respond filed.
Petition for a writ of certiorari filed. (Response due May 16, 2013)
Application (12A818) granted by Justice Kennedy extending the time to file until April 12, 2013.
Application (12A818) to extend the time to file a petition for a writ of certiorari from February 26, 2013 to April 27, 2013, submitted to Justice Kennedy.
James R. Clayworth, et al., Petitioner, represented by Joseph M. Alioto
Abbott Laboratories, Respondent, represented by James F. Hurst
Allergan, Inc., Respondent, represented by Jeffrey T. Thomas
Amgen, Inc., Respondent, represented by Steven O. Kramer
AstraZeneca, LP, Respondent, represented by Paul R. Johnson
Boehringer Ingelheim Pharmaceuticals, Inc., Respondent, represented by Craig E. Stewart
Bristol-Myers Squibb Company, Respondent, represented by Paul Jeffrey Riehle
Eli Lilly and Company, Respondent, represented by Gary Hansen
GlaxoSmithKline plc, Respondent, represented by Michael Robert Lazerwitz
Hoffmann-La Roche, Inc., Respondent, represented by Dorothy Alicia Hickok
Merck Sharp & Dohme Corp., Respondent, represented by Scott H. Christensen
Novartis Pharmaceuticals Corporation, Respondent, represented by Saul P. Morgenstern
Pfizer, Inc., et al., Respondent, represented by Madeleine Marie McDonough
Pharmaceutical Research and Manufacturers of America (PhRMA), Respondent, represented by Lori Alvino McGill